News
Coronavirus Disease 2019 (COVID-19) Update
Counterfeiters Pounce on Coronavirus Fears, Federal Regulators Respond
NABP Supports Boards of Pharmacy to Expedite Emergency Licensure for Pharmacists and Pharmacy Technicians
Coronavirus Disease 2019 (COVID-19) Update
Joint Statement of FSMB and NABP on Inappropriate Prescribing and Dispensing of Medications During the COVID-19 Pandemic
U.S. Healthcare Licensing and Regulatory Organizations Issue Joint Statement on COVID-19 Pandemic
NABP Coronavirus Update
Lemrey “Al” Carter, MS, PharmD, RPh, Named New Executive Director/Secretary of NABP
FDA Thwarts 500 Illicit Drug Shipments in Partnership With Indian Officials
Topics
- Adverse Drug Events
- Committee and Task Force Reports
- Compounding
- Controlled Substances
- Coronavirus disease 2019 (COVID-19)
- Counterfeit Drugs
- Diversion
- Federal Regulations
- Innovations
- Internet Pharmacies
- Medication Collection and Disposal
- Medication Errors
- Medication Therapy Management
- NABP Program
- Officer Reports
- Patient Safety
- Pharmacies
- Pharmacist Licensure
- Practitioner Prescriber
- Prescription Drug Abuse
- Prescription Monitoring Program
- Prescriptions
- Resolutions
- State Rules and Regulations
- Technician Licensure or Certification
- Uncategorized